Stockhead on MSN
Health Check: Biotechs canter into November, but the ‘favourites’ have lead in their saddlebags
The ASX biotech sector ran strongly in October, but the big-cap thoroughbreds found the track conditions more challenging.
9hon MSN
How Josh Giddey shifted Bulls’ trajectory by going from shooting liability to 3-point marksman
The evolution of Josh Giddey as a potent shooter from the three point line is good for him and for the Chicago Bulls.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback